Stoke Therapeutics, Inc.
STOK
$9.66
$0.303.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 61.12% | -7.69% | 16.18% | -16.98% | -5.08% |
| Total Depreciation and Amortization | -15.71% | -15.23% | -10.31% | -5.70% | 2.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.78% | 7.49% | 7.39% | -8.24% | 6.11% |
| Change in Net Operating Assets | -2,205.83% | -823.93% | -102.80% | 20.18% | 75.06% |
| Cash from Operations | -12.32% | -25.22% | 19.83% | -15.03% | 7.71% |
| Capital Expenditure | 81.66% | 73.11% | 94.52% | 92.73% | 44.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -94.26% | -299.34% | -462.92% | -81.22% | -34.49% |
| Cash from Investing | -94.46% | -305.27% | -476.08% | -81.18% | -34.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -92.26% | 1,351.78% | 251,254.17% | -96.19% | 17,383.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -92.26% | 1,351.78% | 251,254.17% | -96.19% | 16,976.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,588.46% | -1,986.41% | 765.49% | -116.75% | 815.63% |